Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 393 of 1,261
  1. US 10799559

    NOPE for treatment of pathological muscle loss and weakness

    Five Prime Therapeutics, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  2. US 10799588

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  3. US 10799580

    Expression vector delivery system and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  4. US 10799585

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  5. US 10799576

    RSV vaccines and methods of production and use thereof

    The Board of Regents for Oklahoma State University · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  6. US 10799584

    Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  7. US 10799593

    Nanodiamond particle complexes

    Northwestern University · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  8. US 10799590

    Compositions containing a bitter tastant and at least one sophorolipid, and methods of reducing bitter taste attributed to a bitter tastant in an edible composition

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  9. US 10799604

    Biopolymer-nanoparticle composite implant for tumor cell tracking

    Northwestern University · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  10. US 10799620

    Ring and tubular structures and methods of synthesis and use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  11. US 10799713

    Miniature wearable laser treatment device

    Veralase, LLC · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  12. US 10800734

    Memantine compounds and their preparation and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  13. US 10800749

    Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them

    The Regents of the University of California · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  14. US 10800753

    Tetrahydrothiophene-based GABA aminotransferase inactivators and analogs thereof for treating neurological disorders

    Northwestern University · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  15. US 10800754

    Heterocyclic amide compound

    Takeda Pharmaceutical Company Limited · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  16. US 10800775

    Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same

    Aclaris Therapeutics, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  17. US 10800774

    Heterocyclic inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  18. US 10800782

    Inhibitors of cellular metabolic processes

    Agios Pharmaceuticals, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  19. US 2020318108

    MATERIALS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 2A AND/OR NON-SYNDROMIC AUTOSOMAL RECESSIVE RETINITIS PIGMENTOSA (ARRP)

    CRISPR THERAPEUTICS AG [CH] · Granted Oct 8, 2020 · Expires Oct 3, 2040

    granted
  20. US 10792287

    Methods for treating mitochondrial diseases

    The Regents of the University of California · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  21. US 10792246

    Film formulations containing dexmedetomidine and methods of producing them

    BioXcel Therapeutics, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  22. US 10793543

    Selective C-KIT kinase inhibitor

    HEFEI GRACEVO BIO-MEDICINE CO., LTD · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  23. US 10793855

    Compositions for modulating expression of C9ORF72 antisense transcript

    Ionis Pharmaceuticals, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  24. US 10792327

    Supramolecular gylcosaminoglycans

    Northwestern University · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.